Home
  • About
  • Technology
    • Our Technology
    • Novel Biologics
    • Fab Platform
    • Follow-on Biologics
    • Life-cycle Management
  • Services
    • Client Services
  • News & Events
    • Press Releases
    • Publications
    • Events

  • Press Releases
  • Publications
  • Events

1/21/2013

Lonza to Evaluate BaroFold’s Protein Refolding Technology

11/13/2012

Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology

11/13/2012

Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis

2/11/2011

BaroFold’s PreEMT Technology Scaled for Phase 3 Clinical Production

05/17/2010

BaroFold Grants Exclusive License for Interferon Beta Products Developed Using PreEMT™ Technology to Nuron Biotech

© BaroFold, Inc. 2010
All Rights Reserved.
  • HOME
  • Events
  • Contact
  • Terms of Use